KZA 0.00% 8.0¢ kazia therapeutics limited

Ann: Trading Halt, page-41

  1. 1,143 Posts.
    lightbulb Created with Sketch. 817
    Epigenetic and CAR T cell Targeting of Diffuse Intrinsic Pontine Glioma

    This is the article where Dr Matt Dun recently hosted a HMIvirtual conference discussing the research from A/Prof Nicholas Vitanza, at
    Seattle Children's Hospital.
    The research targets children with the H3 K27M mutant (DMG), and also targets HER2-positive CNS tumors.in his trials.
    IMO maybe this could add another paxalisib combination trial to commence in the Matt Dun Lab regarding his research into DIPG / DMG.

    https://hotcopper.com.au/data/attachments/3100/3100672-bec06ee9b32d4ba8e97ed84b1940e69d.jpg
    Regards.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.